Call: +7 771 977 66 65, +7 705 421 2277
Sign in or Register
My basket

Astana Biomed Group, an authorized Abcam distributor in Central Asia

Abiomed homepage

  • Categories
    Signal Transduction
    Cancer
    Epigenetics and Nuclear Signaling
    Immunology
    Cell Biology
    Cardiovascular
    Neuroscience
    Tags & Cell Markers
    Kits/ Lysates/ Other
    Developmental Biology
    Microbiology
    Biochemicals
    Secondary antibodies
    Isotype/Loading Controls
    Antibody Arrays
  • About us
  • Partners
  • Contact
    Address

    Saryarka 32, 18, 010000, Astana city, Kazakhstan

    Telephone +7 771 977 66 65, +7 705 421 2277

    Email

    laboratory@ctlab.kz, orders@abiomed.kz

Back to category
Neuroscience Neurotransmission Receptors / Channels Potassium Channels

Verapamil hydrochloride, L-type Ca2+ channel blocker (ab120140)

Price and availability

53 606 ₸

Availability

Order now and get it on Thursday February 25, 2021

Key features and details

  • L-type Ca2+ channel blocker
  • CAS Number: 152-11-4
  • Purity: > 99%
  • Soluble in water to 50 mM
  • Form / State: Solid
  • Source: Synthetic

You may also be interested in

Product image
Apamin, blocker of small conductance Ca2+-activated K+ channels (ab120268)
Etodolac, COX-2 inhibitor NSAID (ab141086)
Product image
Anti-KCNQ4 antibody [N43/6] (ab84820)
Product image
Anti-KCTD3 antibody [EPR14398] - C-terminal (ab184561)

Overview

  • Product name

    Verapamil hydrochloride, L-type Ca2+ channel blocker
  • Description

    L-type Ca2+ channel blocker
  • Biological description

    L-type Ca2+ channel blocker. Antiarrhythmic in vivo.

    Also available in simple stock solutions (ab146680) - add 1 ml of water to get an exact, ready-to-use concentration.

  • Purity

    > 99%
  • CAS Number

    152-11-4
  • Chemical structure

    Chemical Structure

Images

Please note: All products are "FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES"
For licensing inquiries, please contact partnerships@abcam.com

Get resources and offers direct to your inbox Sign up
© 2021 Astana Biomed Group LLP. All rights reserved.